Open with CtrlK — press Esc to close
The Food and Drug Administration approved Mimrylo (rusfertide) on Aug. 28 for adults with polycythemia vera, a rare blood disorder in which the body produces too many red blood cells. The approval…
A ten-author team posted a laboratory analysis on Aug. 26 reporting three distinct phases of organic matter inside Antarctic micrometeorites of probable cometary origin, one of them nitrogen-rich and…
The security firm VulnCheck said on Aug. 27 that it had found two more implants built into the shipped firmware of routers made by Shenzhen Zhibotong Electronics, or ZBT, and that its own internet…
A rubidium atom interferometer aboard the China Space Station has completed an in-orbit quantum test of the weak equivalence principle, the rule that objects fall at the same rate regardless of what…
Blood thinners lowered the rate of serious cardiovascular events in people with atrial fibrillation whose stroke risk is classed as intermediate, according to results from the SINGLE-AF trial…
A study published on Aug. 28, 2026, in Environmental Research Letters projects that heat stress on crops and farm workers leaves global economic output roughly 1% lower by 2100 under a…
A phase III trial of the gene-silencing drug eplontersen in patients whose hearts are stiffened by protein deposits did not meet its primary endpoint, the European Society of Cardiology reported on…
Researchers at Harvard's Wyss Institute have engineered a marine bacterium to make the mineral olivine dissolve faster, and measured carbon dioxide being pulled out of the air in a pilot-scale tank…
Tencent released Hy4 preview on Aug. 28 and published the model's weights on Hugging Face, where the repository carries an Apache 2.0 license, terms that permit commercial use, modification and…
Chipmaker SK Hynix broke ground Aug. 27 on a plant in West Lafayette, Indiana, that the company says will be its first US base for producing high-bandwidth memory, the stacked DRAM used in AI…
Researchers at the University of California, San Francisco have mapped the protein partners of 100 genes strongly associated with autism spectrum disorder and report more than 1,800 interactions…
The U.S. Food and Drug Administration approved Lisraya (brepocitinib) tablets for the treatment of dermatomyositis in adults, according to an agency announcement on Aug. 27, 2026. The approval was…